Phio Pharmaceuticals Corp.
RNA interference in dermal and fibrotic indications
Last updated:
Abstract:
The present invention relates to RNAi constructs with improved tissue and cellular uptake characteristics and methods of use of these compounds in dermal and fibrotic applications.
Status:
Grant
Type:
Utility
Filling date:
12 Mar 2018
Issue date:
9 Feb 2021